BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14525902)

  • 1. Diabetes may be independent risk factor for hyperkalaemia.
    Jarman PR; Mather HM
    BMJ; 2003 Oct; 327(7418):812. PubMed ID: 14525902
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
    Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety in patients with heart failure.
    Juurlink DN; Hansten PD
    Arch Intern Med; 2005 Jan; 165(1):118. PubMed ID: 15642888
    [No Abstract]   [Full Text] [Related]  

  • 5. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
    Jarman PR; Keheley AM; Mather HM
    Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
    [No Abstract]   [Full Text] [Related]  

  • 6. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
    Odawara M; Asano M; Yamashita K
    Diabet Med; 1997 Feb; 14(2):169-70. PubMed ID: 9047098
    [No Abstract]   [Full Text] [Related]  

  • 7. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
    Berry C; McMurray J
    Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced hyperkalaemia is frequent.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17323523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS; Cruz AA; Marcílio de Souza CA
    Nephrol Dial Transplant; 2003 Sep; 18(9):1814-9. PubMed ID: 12937229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkalaemia in the age of aldosterone antagonism.
    Chapagain A; Ashman N
    QJM; 2012 Nov; 105(11):1049-57. PubMed ID: 22723454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I; Yalcin S; Ozhan H
    Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS; Cruz LS; Domingues GS; Souza CA
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
    Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH
    BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459
    [No Abstract]   [Full Text] [Related]  

  • 15. Junctional escape rhythm secondary to acute hyperkalemic renal failure in the setting of concurrent beta-blocker therapy.
    Isabel J; Champion JC
    JAAPA; 2006 Dec; 19(12):78. PubMed ID: 17243264
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C; Wani M; Steward J; O'Mahony MS
    Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
    [No Abstract]   [Full Text] [Related]  

  • 17. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN; Mamdani MM; Lee DS; Kopp A; Austin PC; Laupacis A; Redelmeier DA
    N Engl J Med; 2004 Aug; 351(6):543-51. PubMed ID: 15295047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
    Gottlieb S
    BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321896
    [No Abstract]   [Full Text] [Related]  

  • 19. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
    Lenz T
    MMW Fortschr Med; 2005 Jan; 147(4):59-60. PubMed ID: 15745346
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.